Skip to main content
Top
Published in: BMC Palliative Care 1/2014

Open Access 01-12-2014 | Research article

Corticosteroids in palliative care - perspectives of clinicians involved in prescribing: a qualitative study

Authors: Anne Denton, John Shaw

Published in: BMC Palliative Care | Issue 1/2014

Login to get access

Abstract

Background

Corticosteroids are commonly prescribed in palliative care for alleviation of both specific and non-specific symptoms, but relatively little is known of the perspectives of clinicians and what influences their prescribing in this context. The aim of this study was to explore the experiences and perspectives of those involved in the prescribing of corticosteroids in palliative care.

Methods

Semi-structured interviews were undertaken with 12 medical practitioners and six senior nurses from a sample of six New Zealand hospices to identify their experiences and attitudes regarding the prescribing of corticosteroids. A general inductive approach was used to thematically analyse data.

Results

Five broad themes were identified: the role of corticosteroids in palliative care; indications for corticosteroids; influences on prescribing; use of guidelines; and perceptions of previous study data on prescribing patterns for their hospice. Interviewees regarded these agents as having an important place in in palliative care but expressed a degree of uncertainty about certain aspects of their use. They were concerned about issues such as prescribing for non-specific indications, methods of stopping, and lack of monitoring and reviewing. Guidelines were used routinely by only one of the sample hospices. Corticosteroids tended to be prescribed experientially or by habit, rather than based on evidence-based guidelines.

Conclusions

This study has highlighted differences in the understanding of the place of corticosteroids in palliative care by the clinicians interviewed in this study and different practices, particularly in the treatment of non-specific symptoms and in the use of guidelines. These findings suggest a need for further research and discussion about the role of corticosteroids in palliative care and the development of evidence-based guidelines to assist prescribers.
Literature
1.
go back to reference Kiani M, Yip AYM, Tuffin PHR, Roberts M, Clifford RM: Dexamethasone use in inpatient palliative care. J Pharm Pract Res. 2011, 41: 217-220.CrossRef Kiani M, Yip AYM, Tuffin PHR, Roberts M, Clifford RM: Dexamethasone use in inpatient palliative care. J Pharm Pract Res. 2011, 41: 217-220.CrossRef
2.
go back to reference Lundstrom SH, Furst CJ: The use of corticosteroids in Swedish palliative care. Acta Oncol. 2006, 45: 430-437. 10.1080/02841860500401167.CrossRefPubMed Lundstrom SH, Furst CJ: The use of corticosteroids in Swedish palliative care. Acta Oncol. 2006, 45: 430-437. 10.1080/02841860500401167.CrossRefPubMed
3.
go back to reference Matsuo N, Morita T, Iwase S: Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. J Palliat Med. 2011, 14: 840-845. 10.1089/jpm.2011.0002.CrossRefPubMed Matsuo N, Morita T, Iwase S: Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. J Palliat Med. 2011, 14: 840-845. 10.1089/jpm.2011.0002.CrossRefPubMed
4.
go back to reference Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, Neuwöhner K, Schulenberg D, Radbruch L: Drugs in palliative care: results from a representative survey in Germany. Palliat Med. 2004, 18: 100-107. 10.1191/0269216304pm852oa.CrossRefPubMed Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, Neuwöhner K, Schulenberg D, Radbruch L: Drugs in palliative care: results from a representative survey in Germany. Palliat Med. 2004, 18: 100-107. 10.1191/0269216304pm852oa.CrossRefPubMed
5.
go back to reference Twycross R, Bergl S, John S, Lewis K: Monitoring drug use in palliative care. Palliat Med. 1994, 8: 137-143. 10.1177/026921639400800207.CrossRefPubMed Twycross R, Bergl S, John S, Lewis K: Monitoring drug use in palliative care. Palliat Med. 1994, 8: 137-143. 10.1177/026921639400800207.CrossRefPubMed
6.
go back to reference Klepstad P, Kaasa S, Cherny N, Hanks G, de Conno F, Research Steering Committee of the EAPC: Pain and pain treatments in European palliative care units. A cross sectional survey from the European association for palliative care research network. Palliat Med. 2005, 19: 477-484. 10.1191/0269216305pm1054oa.CrossRefPubMed Klepstad P, Kaasa S, Cherny N, Hanks G, de Conno F, Research Steering Committee of the EAPC: Pain and pain treatments in European palliative care units. A cross sectional survey from the European association for palliative care research network. Palliat Med. 2005, 19: 477-484. 10.1191/0269216305pm1054oa.CrossRefPubMed
7.
go back to reference Pilkey J, Daeninck PJ: A retrospective analysis of dexamethasone use on a Canadian palliative care unit. Prog Palliat Care. 2008, 16: 63-68. 10.1179/096992608X257610.CrossRef Pilkey J, Daeninck PJ: A retrospective analysis of dexamethasone use on a Canadian palliative care unit. Prog Palliat Care. 2008, 16: 63-68. 10.1179/096992608X257610.CrossRef
8.
go back to reference Shafford E: Is corticosteroid prescribing appropriate in palliative care?. Eur J Palliat Care. 2006, 13: 202-204. Shafford E: Is corticosteroid prescribing appropriate in palliative care?. Eur J Palliat Care. 2006, 13: 202-204.
9.
go back to reference Mercadante S, Fulfaro F, Casuccio A: Pattern of drug use by advanced cancer patients followed at home. J Pall Care. 2001, 17: 37-40. Mercadante S, Fulfaro F, Casuccio A: Pattern of drug use by advanced cancer patients followed at home. J Pall Care. 2001, 17: 37-40.
10.
go back to reference Hanks GWC, Trueman T, Twycross R: Corticosteroids in terminal cancer - a prospective analysis of current practice. Postgrad Med J. 1983, 59: 702-706. 10.1136/pgmj.59.697.702.CrossRefPubMedPubMedCentral Hanks GWC, Trueman T, Twycross R: Corticosteroids in terminal cancer - a prospective analysis of current practice. Postgrad Med J. 1983, 59: 702-706. 10.1136/pgmj.59.697.702.CrossRefPubMedPubMedCentral
12.
go back to reference Hardy J: Corticosteroids in palliative care. Eur J Palliat Care. 1998, 5: 46-50. Hardy J: Corticosteroids in palliative care. Eur J Palliat Care. 1998, 5: 46-50.
13.
go back to reference Gannon C, McNamara P: A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage. 2002, 24: 328-334. 10.1016/S0885-3924(02)00487-6.CrossRefPubMed Gannon C, McNamara P: A retrospective observation of corticosteroid use at the end of life in a hospice. J Pain Symptom Manage. 2002, 24: 328-334. 10.1016/S0885-3924(02)00487-6.CrossRefPubMed
14.
go back to reference Denton A, Shaw J: Corticosteroid prescribing in palliative care settings: a retrospective analysis in New Zealand. BMC Pall Care. 2014, 13: 7-10.1186/1472-684X-13-7.CrossRef Denton A, Shaw J: Corticosteroid prescribing in palliative care settings: a retrospective analysis in New Zealand. BMC Pall Care. 2014, 13: 7-10.1186/1472-684X-13-7.CrossRef
15.
go back to reference Bruera E, Moyano JR, Sala R, Rico MA, Bosnjak S, Bertolino M, Willey J, Strasser F, Palmer JL: Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage. 2004, 28: 381-388. 10.1016/j.jpainsymman.2004.01.009.CrossRefPubMed Bruera E, Moyano JR, Sala R, Rico MA, Bosnjak S, Bertolino M, Willey J, Strasser F, Palmer JL: Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage. 2004, 28: 381-388. 10.1016/j.jpainsymman.2004.01.009.CrossRefPubMed
16.
go back to reference Bruera E, Roca E, Cedaro I, Carraro S, Chacon R: Action of oral methylprednisolone in terminal cancer patients: a prospective randomised double blind study. Cancer Treat Rep. 1985, 69: 751-754.PubMed Bruera E, Roca E, Cedaro I, Carraro S, Chacon R: Action of oral methylprednisolone in terminal cancer patients: a prospective randomised double blind study. Cancer Treat Rep. 1985, 69: 751-754.PubMed
17.
go back to reference Della Cuna GR, Pellegrini A, Piazzi M: Effect of methylprednisolone sodium succinate on quality of life in pre-terminal cancer patients: a placebo-controlled, multicenter study. The methylprednisolone preterminal cancer study group. Eur J Cancer Clin Oncol. 1989, 25: 1817-1821. 10.1016/0277-5379(89)90353-2.CrossRefPubMed Della Cuna GR, Pellegrini A, Piazzi M: Effect of methylprednisolone sodium succinate on quality of life in pre-terminal cancer patients: a placebo-controlled, multicenter study. The methylprednisolone preterminal cancer study group. Eur J Cancer Clin Oncol. 1989, 25: 1817-1821. 10.1016/0277-5379(89)90353-2.CrossRefPubMed
18.
go back to reference Mercadante S, Berchovich M, Casuccio A, Fulfaro F, Mangione S: A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hospice Pall Care. 2007, 24: 13-19. 10.1177/1049909106295431.CrossRef Mercadante S, Berchovich M, Casuccio A, Fulfaro F, Mangione S: A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hospice Pall Care. 2007, 24: 13-19. 10.1177/1049909106295431.CrossRef
19.
go back to reference Popiela T, Lucchi R, Giongo F: Methylprednisolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol. 1989, 25: 1823-1829. 10.1016/0277-5379(89)90354-4.CrossRefPubMed Popiela T, Lucchi R, Giongo F: Methylprednisolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol. 1989, 25: 1823-1829. 10.1016/0277-5379(89)90354-4.CrossRefPubMed
20.
go back to reference Kaal ECA, Vecht CJ: The management of brain edema in brain tumors. Curr Opin Oncol. 2004, 16: 593-600. 10.1097/01.cco.0000142076.52721.b3.CrossRefPubMed Kaal ECA, Vecht CJ: The management of brain edema in brain tumors. Curr Opin Oncol. 2004, 16: 593-600. 10.1097/01.cco.0000142076.52721.b3.CrossRefPubMed
21.
go back to reference Weissman DE: Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol. 1988, 6: 543-551.PubMed Weissman DE: Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol. 1988, 6: 543-551.PubMed
22.
go back to reference Sweeney C, Bruera E: New roles for old drugs: corticosteroids. Prog Palliat Care. 2001, 9: 2. Sweeney C, Bruera E: New roles for old drugs: corticosteroids. Prog Palliat Care. 2001, 9: 2.
23.
go back to reference Peuckmann V, Elsner F, Krumm N, Trottenburg P, Radbruch L: Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010, 10 (11): CD006788 Peuckmann V, Elsner F, Krumm N, Trottenburg P, Radbruch L: Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2010, 10 (11): CD006788
24.
go back to reference Bruera E: Is the pharmacological treatment of cachexia possible?. Support Care Cancer. 1993, 1: 298-304. 10.1007/BF00364967.CrossRefPubMed Bruera E: Is the pharmacological treatment of cachexia possible?. Support Care Cancer. 1993, 1: 298-304. 10.1007/BF00364967.CrossRefPubMed
25.
go back to reference Moertel CG, Schutt AJ, Reiteneier RJ, Hahn RG: Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer. 1974, 33: 1607-1609. 10.1002/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V.CrossRefPubMed Moertel CG, Schutt AJ, Reiteneier RJ, Hahn RG: Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer. 1974, 33: 1607-1609. 10.1002/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V.CrossRefPubMed
26.
go back to reference Abbas SQ: Management of the adverse effects of corticosteroids. Eur J Palliat Care. 2004, 11: 49-52. Abbas SQ: Management of the adverse effects of corticosteroids. Eur J Palliat Care. 2004, 11: 49-52.
27.
go back to reference Wooldridge JE, Anderson CM, Perry MC, Smith NB: Corticosteroids in advanced cancer. Oncology. 2001, 15: 225-232.PubMed Wooldridge JE, Anderson CM, Perry MC, Smith NB: Corticosteroids in advanced cancer. Oncology. 2001, 15: 225-232.PubMed
28.
go back to reference Hardy J, Rees E, Ling J, Burman R, Feuer D, Broadley K, Stone P: A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med. 2001, 15: 3-8. 10.1191/026921601673324846.CrossRefPubMed Hardy J, Rees E, Ling J, Burman R, Feuer D, Broadley K, Stone P: A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med. 2001, 15: 3-8. 10.1191/026921601673324846.CrossRefPubMed
29.
go back to reference Gannon C: The prescription of steroids in the terminal phase. Palliat Med. 2001, 15: 22.CrossRef Gannon C: The prescription of steroids in the terminal phase. Palliat Med. 2001, 15: 22.CrossRef
30.
go back to reference Rousseau P: Sudden withdrawal of corticosteroids: a commentary. Am J Hospital Palliat Care. 2004, 21: 169-171. 10.1177/104990910402100302.CrossRef Rousseau P: Sudden withdrawal of corticosteroids: a commentary. Am J Hospital Palliat Care. 2004, 21: 169-171. 10.1177/104990910402100302.CrossRef
32.
go back to reference Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006, 18: 59-82. 10.1177/1525822X05279903.CrossRef Guest G, Bunce A, Johnson L: How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006, 18: 59-82. 10.1177/1525822X05279903.CrossRef
33.
go back to reference Davis EM, Jamison P, Brumley R, Enguídanos S: Barriers and facilitators to replicating an evidence-based palliative care model. Home Health Care Serv Q. 2006, 25: 149-165. 10.1300/J027v25n01_08.CrossRefPubMed Davis EM, Jamison P, Brumley R, Enguídanos S: Barriers and facilitators to replicating an evidence-based palliative care model. Home Health Care Serv Q. 2006, 25: 149-165. 10.1300/J027v25n01_08.CrossRefPubMed
34.
go back to reference Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E: Reduction of cancer-related fatigue with dexamethasone: a double-blind randomized placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013, 31: 3076-3082. 10.1200/JCO.2012.44.4661.CrossRefPubMed Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E: Reduction of cancer-related fatigue with dexamethasone: a double-blind randomized placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013, 31: 3076-3082. 10.1200/JCO.2012.44.4661.CrossRefPubMed
Metadata
Title
Corticosteroids in palliative care - perspectives of clinicians involved in prescribing: a qualitative study
Authors
Anne Denton
John Shaw
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2014
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/1472-684X-13-50

Other articles of this Issue 1/2014

BMC Palliative Care 1/2014 Go to the issue